Breakthrough cancer drug doubles survival in trial
by ausbah on 5/31/2025, 2:25:07 PM
> The new approach showed positive results. It doubled the length of time patients were cancer free, on average, from around 2.5 years to five years.
seems like a slightly misleading title
> The new approach showed positive results. It doubled the length of time patients were cancer free, on average, from around 2.5 years to five years.
seems like a slightly misleading title